Comprehensive Cell Solutions Capacity Update April 2025: Cell & Gene Therapy

New York Blood Center Enterprises (NYBCe) has been a leader in blood and transfusion medicine for over 60 years, expanding its expertise into cell, gene, and regenerative therapies through its business unit, Comprehensive Cell Solutions (CCS). CCS serves as a premier CDMO, offering end-to-end solutions that support therapeutic developers from early-stage research through commercial manufacturing.

With a national network of facilities, CCS provides apheresis collections, GMP manufacturing, cryopreservation, analytical testing, and supply chain logistics. Its state-of-the-art sites include a specialized development site in Houston, Texas, and collections and manufacturing sites in Rye, New York, and Louisville, Kentucky, ensuring streamlined, high-quality support for hospitals, academic institutions, biotech and pharma companies.

The Louisville facility has been a key part of CCS’s expansion, strategically located in the University of Louisville’s Biomedical Campus, providing access to top medical institutions and making it an ideal hub for clinical trials. With a diverse patient population and a growing life sciences ecosystem, Louisville and its neighboring states are becoming an increasingly attractive destination for CGT development. Its proximity to UPS Healthcare Precision Logistics Hub, one of the world’s largest logistics centers, further strengthens its capabilities and geographic coverage. Through a partnership with UPS Express Critical, CCS ensures real-time tracking and rapid transportation of irreplaceable biomaterials, delivering time-sensitive therapies anywhere in the U.S. within hours.

Join us for this presentation to explore how NYBCe and CCS are revolutionizing CGT manufacturing and logistics, and learn why Louisville is becoming a central hub for cell therapy innovation.

Capabilities:

• Our Draw-to-Thaw™ solution, tailored to client needs
• Characterization of cellular starting material
• Process and analytical method development
• Technology transfer
• Platform-agnostic GTP and GMP manufacturing
• Cryopreservation & Storage
  • Associated support services: CMC Regulatory, Logistics, PM & Vector Production through strategic partners